Genetic Engineering & Biotechnology News

JUL 2017

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link:

Contents of this Issue


Page 18 of 45

Breakthroughs in treatment have given hope to many patients w it h ra re d isea ses. Yet, ba r r iers to acces sing t hese l ife - changing treatments remain. Specialized commercialization strategies designed with the patient's treatment experience in mind optimize product access while ensuring cost and logistical effi ciencies. Working with a greater purpose takes understanding that every patient matters. It takes AmerisourceBergen. C L I N I C A L T R I A L L O G I S T I C S \ M A R K E T A C C E S S C O N S U L T I N G \ PAT I E N T A C C E S S & A D H E R E N C E \ S P E C I A L T Y R X , 3 P L , G P O S \ D I S T R I B U T I O N

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - JUL 2017